Scientists Are Developing Brain Implants That Could Revolutionize Parkinson’s Treatment

Parkinson expects an upcoming test even if there is no cure for the disease More than 10 million Life with the disorder that can be on the horizon.

A group of researchers led by scientists at the University of Cambridge plans to develop a new type of brain implant from small clusters of brain cells to treat Parkinson’s disease. This approach, such as details at a university Statement From January 25, the neural paths affected by aggressive diseases will be repaired and first tested on animals.

George Maliaras from the University of Cambridge, “Our ultimate goal is to create the right brain therapy that can restore common brain functioning among the people of Parkinson, who will give co-leadership of the project with Cambridge researcher Roger Barker.

Parkinson A progressive neurodizerrative disorder producing dopamine, especially due to the breakdown and death of neurons in the brain. The decrease dopamine levels disrupt the normal brain activity, affecting motor control and causing movement problems. Scientists do not know what the disease triggers and there is no cure at present. Although dopamine-based drugs are early in treatment, they often lead to significant and unpleasant side effects over time.

Scientists have been Search for a cure For more than a century for Parkinson’s disease. Researchers are exploring Cell-replacement therapy As a possible treatment, which replaces dead dopamine cells with new. These current methods, however, failed to completely integrate the cells that replace the brain’s nervous system.

Maliarus and Barker’s team is hopeful that transplants made from small clusters of brain cells will solve this problem. Like cell-replacement therapy, researchers are planning to replace these midbrane organized to the brain. Then, they will use “advanced materials and electric stimulation” to recover the lost neural paths to replace the nervous system.

“To this day, there has been a very serious investment in methods that interface with the human brain beyond the ‘Brut Force’ method or very aggressive implant,” Jack Carolan, the program director of the Advanced Research Agency (ARIA), says. Arya is funding the Implant Project of Parkinson, the British Research and Development Agency. “We have shown that it is possible to develop elegant ways to understand, identify and treat many complex and destructive brain diseases. In the end, it can provide the converter effect for people with living experiences of brain disorders. “

There is still a matter of seeing how the team will develop the implant after the project officially started. Hopefully, within a few years – or probably a few months – we will report on the success of the first animal test.